Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

China flag China · Delayed Price · Currency is CNY
27.14
+0.11 (0.41%)
Apr 30, 2026, 3:00 PM CST
-11.57%
Market Cap 3.68B
Revenue (ttm) 1.34B
Net Income (ttm) 152.02M
Shares Out 135.44M
EPS (ttm) 1.12
PE Ratio 24.23
Forward PE n/a
Dividend 0.40 (1.48%)
Ex-Dividend Date Jun 13, 2025
Volume 1,340,260
Average Volume 1,203,444
Open 27.21
Previous Close 27.03
Day's Range 26.75 - 27.41
52-Week Range 23.24 - 33.34
Beta 0.17
RSI 60.43
Earnings Date Apr 28, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material techno... [Read more]

Sector Healthcare
Founded 2000
Employees 711
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603351
Full Company Profile

Financial Performance

In 2025, SHA:603351's revenue was 1.34 billion, an increase of 2.95% compared to the previous year's 1.30 billion. Earnings were 150.97 million, an increase of 3.11%.

Financial Statements

News

There is no news available yet.